Moustafa Abdou: New Horizons in Hematology and Recent Drug Approvals
Moustafa Abdou, Author and Founder of AskHematologist.com, shared a post on LinkedIn:
“New Horizons in Hematology: A Review of Recent Drug Approvals
Recent advances in hematology are rapidly transforming the management of both malignant and non-malignant blood disorders.
From gene therapy and non-factor treatments in hemophilia to targeted therapies such as JAK inhibitors and antibody–drug conjugates in hematologic malignancies, modern therapeutics are increasingly driven by precision medicine and molecular targeting.
Agents such as brentuximab vedotin have redefined lymphoma treatment, while ruxolitinib has significantly improved outcomes in myeloproliferative neoplasms.
In resistant leukemias, novel agents like omacetaxine offer alternative mechanisms to overcome treatment resistance.
Equally important are advances in supportive care.
G-CSF therapies, iron chelation, direct oral anticoagulants, and enzyme replacement therapies have reduced complications and improved quality of life across a wide range of hematologic conditions.
These developments highlight a comprehensive shift toward more effective, personalised, and safer treatment strategies in hematology.”
Stay updated with Hemostasis Today.
-
Jun 8, 2026, 03:05Shamsunisha Yusuff: Iron Down, Platelets Up in a Young CBC ?
-
Jun 8, 2026, 03:03Samwel Mikaye: D-Dimer – A Marker of Blood Clot Breakdown
-
Jun 8, 2026, 02:59Vinita Madhuri: Our Engagement, A Lifeline for Thalassemia Patients
-
Jun 7, 2026, 22:11Lucia Härtel: Exercise, IL-10 Signaling, and Post-Stroke Brain Plasticity
-
Jun 7, 2026, 19:35Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?
-
Jun 7, 2026, 18:25Nita Radhakrishnan: Every Child Cured Is a Reminder of What Can Be Achieved When We Work Together
-
Jun 7, 2026, 18:24Yvette Fairfax: Wiskott-Aldrich Gene Therapy Changes Immunity, but Affordability May Determine Survival
-
Jun 7, 2026, 18:21Gulab Makwana: Complete Guide to Clotting Factors – Understanding the Coagulation System
-
Jun 7, 2026, 18:15Chuhan Dong: Presenting My Research on Antibody-Mediated RBC Clearance at Canadian Blood Services